127 related articles for article (PubMed ID: 21914581)
21. Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
Yoshihara S; Yamada Y; Fukuda H; Tsuchiya T; Ono M; Fukuda N; Kanno N; Arisaka O
Allergol Int; 2014 Jun; 63(2):199-203. PubMed ID: 24561769
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
Yamada Y; Yoshihara S; Arisaka O
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
[No Abstract] [Full Text] [Related]
23. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
24. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
25. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
[No Abstract] [Full Text] [Related]
27. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
28. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
[TBL] [Abstract][Full Text] [Related]
29. Case 36-2007: a woman with rash, fever, and hypotension.
Mir MA; Khalil F
N Engl J Med; 2008 Mar; 358(13):1406; author reply 1406-7. PubMed ID: 18376447
[No Abstract] [Full Text] [Related]
30. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
31. Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study.
Miyachi Y; Katayama I; Furue M
Allergol Int; 2007 Sep; 56(3):269-75. PubMed ID: 17582208
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
33. Progress in suplatast tosilate research.
Sano Y; Yamada H
Clin Exp Allergy; 2007 Jul; 37(7):970-2. PubMed ID: 17581190
[No Abstract] [Full Text] [Related]
34. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
[TBL] [Abstract][Full Text] [Related]
35. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
[TBL] [Abstract][Full Text] [Related]
36. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
Yamasawa H; Oshikawa K; Sugiyama Y
Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
[TBL] [Abstract][Full Text] [Related]
37. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
Nagakura T; Ogino S; Okubo K; Sato N; Takahashi M; Ishikawa T
Clin Exp Allergy; 2008 Feb; 38(2):329-37. PubMed ID: 18070163
[TBL] [Abstract][Full Text] [Related]
38. Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report.
Umemoto S; Itagaki K; Kimura M; Itoh S; Tanaka M; Haraguchi M; Matsuzaki M
Heart Vessels; 2003 May; 18(2):100-2. PubMed ID: 12756607
[TBL] [Abstract][Full Text] [Related]
39. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
[TBL] [Abstract][Full Text] [Related]
40. A case of eosinophilic pneumonia successfully treated with suplatast tosilate alone.
Watanabe N; Hirata A; Makino S; Fukuda T
Int Arch Allergy Immunol; 2009; 149 Suppl 1():94-101. PubMed ID: 19494513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
